Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

It pays to be choosy when investing in China

Ben Johnson, CFA  |  01 Feb 2022Text size  Decrease  Increase  |  
Email to Friend

China looms larger than ever on the world stage and in investors' portfolios. The country's economy has grown to become the second-largest on the globe, and its influence has expanded beyond its borders. But decades of rapid economic expansion haven't translated to commensurate gains for investors.

The Chinese stock market has evolved. In recent years, it has opened up to the outside world. The inclusion of mainland-listed China A-shares in major index providers' mainline indexes is perhaps the most prominent example of the opening of the Chinese capital market. The Chinese stock market has also become more dynamic. Some of the world’s largest technology companies, like Tencent (TCEHY) and Alibaba (BABA), call China home. And in 2019, the Shanghai Stock Exchange STAR Market was established as China's equivalent to the Nasdaq: a hub for China's most innovative firms to raise equity capital.

But as much has changed in China, much remains the same. The Chinese government continues to exert control over economic activity, as evidenced by its recent efforts to pull the plug on for-profit private tutors. The country's reliance on debt to fuel its growth was again in focus as property developer Evergrande Group edged toward a potential default. So, while opportunities abound, so do risks--big ones.

Investors can't ignore China, but they should be choosy when investing there. They may simply decide the risks aren't worth it, or that being more selective--investing in a narrower slice of the market or partnering with an active manager--is best.

Where's the growth?

From 1993 through 2020, China's gross domestic product grew by more than 9% per year. Surely that sort of growth translated to fabulous returns for investors in Chinese stocks, right? Wrong. Over that same span, the MSCI China Index gained just 2.71% on an annualized basis. Chinese stocks' returns were equally or even more disappointing relative to other major markets. During this 27-year period, the MSCI USA Index compounded at 10.37% annually, the MSCI Emerging Markets Index 7.95%, and the MSCI EAFE Index 6.65%. Exhibit 1 plots the relative performance of the MSCI China Index to each of these three, and it isn't a pretty picture.

Exhibit 1

 

You keep saying "China" … I don't think that means what you think it means

It has long been known that the link between economic growth and stock market returns is weak at best and may even be negative. [1] There are a variety of explanations for this. The strongest, in my opinion, is that beginning-of-period valuations are the most meaningful predictor of future returns. But there are other, more fundamental forces at play, too. One that is particularly relevant to the case of China, cited by finance professor Jay Ritter, is that "a country can grow rapidly by applying more capital and labor without the owners of capital earning higher returns." Many investors in Chinese stocks can probably relate.

Investing in Chinese stocks is complicated. There are A-shares, B-shares, H-shares, Red-Chips, P-Chips, and some US-listed ADRs, all of which may be members of a litany of different benchmarks. Defining the Chinese stock market isn't easy, and depending on how you define it, you might come to very different conclusions about its prospects and performance.

Investing Compass
Listen to Morningstar Australia's Investing Compass podcast
Take a deep dive into investing concepts, with practical explanations to help you invest confidently.
Investing Compass

Exhibit 2 shows the dispersion of the rolling 12-month returns among four exchange-traded funds investing in Chinese stocks. This spread peaked in May 2015, when the difference between Xtrackers Harvest CSI 300 China A ETF's (ASHR) 12-month return and SPDR S&P China ETF's (GXC) registered at 95 percentage points. What a difference a definition makes!

Exhibit 2

ASHR tracks the CSI 300 Index, which consists of China A-shares. GXC is underpinned by the S&P China BMI Index, which invests in the entire alphabet soup of Chinese share classes. In 2015, a debt-fueled stock-buying binge driven by retail investors in mainland China pushed China A-share-focused ASHR up to levels well above its more broadly diversified counterparts--which had yet to include those shares. This episode is a prime example of the importance of knowing what it means to invest in "China."

Is that it?

Have you ever seen the "Mona Lisa" in person? Do you remember the anticipation as you walked down that long, cavernous hallway in the Louvre? Then, you turn the corner. Was your first reaction like mine? I remember saying to myself, "Is that it?" My first impression of what is arguably the most famous painting in the world was that it was much smaller than I'd expected. Similarly, while China looms large in our minds, its footprint in most investors' portfolios is still fairly small despite its growth.

Exhibit 3 puts the size of the Chinese stock market into perspective. Chinese stocks have grown to represent a larger portion of global markets over the past decade. In October 2011, they made up just over 17% of the MSCI Emerging Markets Index. At the end of September 2021, that figure had grown to nearly 34%. Chinese stocks' share of the MSCI All Country World Index grew to 4.1% from 2.2% over this same time frame. Their share of a market-cap-weighted 60/40 stock/bond portfolio expanded to 2.4% from 1.3%. So, in the context of a diversified portfolio, stocks that call the world's second-largest economy home still play a small part. This will be important to remember the next time mainland markets melt down like they did after Chinese retail investors ran for the exits in 2015.

Exhibit 3

Fish in a barrel

Fettered access, government interference, and an investor base that skews heavily toward retail traders make the Chinese stock market a target-rich environment for savvy investors. It may well be the only major market where a majority of professional investors regularly beat their benchmarks. In the latest Morningstar China Active/Passive Barometer, my Shenzhen-based manager research colleagues found that three fourths of actively managed diversified Chinese stock funds available to Chinese investors managed to both survive and outperform their average passive peer over the prior decade.[2] Just 19% of actively managed US stock funds can claim the same over the 10 years through June 2021. Clearly, there are ample opportunities for active managers to add value in China.

Exhibit 4 features three Morningstar Medalists that invest in Chinese stocks. Each delivered the goods over the 10 years through September 2021, handily outperforming iShares MSCI China ETF (MCHI).

Exhibit 4

 

1) Ritter, J.R. 2005. "Economic Growth and Equity Returns," Pacific-Basin Finance Journal, Vol. 13, No. 5, P. 489.

2) https://direct.morningstar.com/research/doc/1041595/The-Morningstar-China-Active-Passive-Barometer-May-2021. (Available to Morningstar Direct subscribers.)

Disclosure: Morningstar, Inc. licenses indexes to financial institutions as the tracking indexes for investable products, such as exchange-traded funds, sponsored by the financial institution. The license fee for such use is paid by the sponsoring financial institution based mainly on the total assets of the investable product. Please click here for a list of investable products that track or have tracked a Morningstar index. Morningstar, Inc. does not market, sell, or make any representations regarding the advisability of investing in any investable product that tracks a Morningstar index.

is director of global exchange-traded fund research for Morningstar.

© 2022 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'regulated financial advice' under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information, refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend